Paper29675428
PTX3: A Potential Biomarker in Thyroid Associated Ophthalmopathy.
Mou P and 4 others. Biomed Res Int, 2018. Cited by 14 papers, by iCite.
Cite this record
ConductScience Library. PTX3: A Potential Biomarker in Thyroid Associated Ophthalmopathy. Papers, record 29675428. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29675428
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Biomarkers | Major topic |
| C-Reactive Protein | Major topic |
| Graves Ophthalmopathy | Major topic |
| Serum Amyloid P-Component | Major topic |
| Thyroid Gland | Major topic |
| Adipose Tissue | |
| Adult | |
| Enzyme-Linked Immunosorbent Assay | |
| Female | |
| Gene Expression | |
| Humans | |
| Male | |
| Orbit | |
| RNA | |
| Pentraxins |
Source PubMed
References21
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19273457 | Increased serum pentraxin 3 in patients with systemic sclerosis. | J Rheumatol | 2009 | https://conductscience.org/library/papers/19273457 | PubMed |
| 2 | 577380 | Modification of the classification of the eye changes of Graves' disease. | Am J Ophthalmol | 1977 | https://conductscience.org/library/papers/577380 | PubMed |
| 3 | 24424182 | Diagnosis and classification of Graves' disease. | Autoimmun Rev | 2014 | https://conductscience.org/library/papers/24424182 | PubMed |
| 4 | 9302365 | Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy. | Clin Endocrinol (Oxf) | 1997 | https://conductscience.org/library/papers/9302365 | PubMed |
| 5 | 10931803 | PTX3, A prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans. | Circulation | 2000 | https://conductscience.org/library/papers/10931803 | PubMed |
| 6 | 26287404 | Pentraxin-3 Is a TSH-Inducible Protein in Human Fibrocytes and Orbital Fibroblasts. | Endocrinology | 2015 | https://conductscience.org/library/papers/26287404 | PubMed |
| 7 | 27116665 | HC-HA/PTX3 Purified From Amniotic Membrane as Novel Regenerative Matrix: Insight Into Relationship Between Inflammation and Regeneration. | Invest Ophthalmol Vis Sci | 2016 | https://conductscience.org/library/papers/27116665 | PubMed |
| 8 | 26885720 | Plasma pentraxin-3 levels in patients with Takayasu's arteritis during routine follow-up. | Clin Exp Rheumatol | 2016 | https://conductscience.org/library/papers/26885720 | PubMed |
| 9 | 20578901 | Risk factors for development or deterioration of Graves' ophthalmopathy. | Thyroid | 2010 | https://conductscience.org/library/papers/20578901 | PubMed |
| 10 | 26323474 | GO-QOL--disease-specific quality of life questionnaire in Graves' orbitopathy. | Endokrynol Pol | 2015 | https://conductscience.org/library/papers/26323474 | PubMed |
| 11 | 18299459 | Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO. | Eur J Endocrinol | 2008 | https://conductscience.org/library/papers/18299459 | PubMed |
| 12 | 25159210 | Elevated plasma pentraxin 3 levels are associated with development and progression of diabetic retinopathy in Korean patients with type 2 diabetes mellitus. | Invest Ophthalmol Vis Sci | 2014 | https://conductscience.org/library/papers/25159210 | PubMed |
| 13 | 25401491 | Pentraxin 3 as a biomarker of local inflammatory response to vascular injury in systemic lupus erythematosus. | Autoimmunity | 2015 | https://conductscience.org/library/papers/25401491 | PubMed |
| 14 | 28420068 | Pentraxin-3 levels are associated with vasculitis and disease activity in childhood-onset systemic lupus erythematosus. | Lupus | 2017 | https://conductscience.org/library/papers/28420068 | PubMed |
| 15 | 19718477 | The long pentraxin 3 (PTX3): a novel prognostic inflammatory marker for mortality in acute chest pain. | Thromb Haemost | 2009 | https://conductscience.org/library/papers/19718477 | PubMed |
| 16 | 21510802 | Gene expression in Graves' ophthalmopathy and arm lymphedema: similarities and differences. | Thyroid | 2011 | https://conductscience.org/library/papers/21510802 | PubMed |
| 17 | 12432394 | Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response. | Nature | 2002 | https://conductscience.org/library/papers/12432394 | PubMed |
| 18 | 24652286 | Constitutive expression of pentraxin 3 (PTX3) protein by human amniotic membrane cells leads to formation of the heavy chain (HC)-hyaluronan (HA)-PTX3 complex. | J Biol Chem | 2014 | https://conductscience.org/library/papers/24652286 | PubMed |
| 19 | 10606983 | Expression and production of the long pentraxin PTX3 in rheumatoid arthritis (RA). | Clin Exp Immunol | 2000 | https://conductscience.org/library/papers/10606983 | PubMed |
| 20 | 27436699 | Changes in the inflammatory markers with advancing stages of diabetic nephropathy and the role of pentraxin-3. | Ren Fail | 2016 | https://conductscience.org/library/papers/27436699 | PubMed |
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41287009 | Integrative transcriptomic profiling and machine learning reveal hypoxia-associated molecular signatures for precision diagnosis in thyroid eye disease. | Hum Genomics | 2025 | https://conductscience.org/library/papers/41287009 | PubMed |
| 39664569 | Multi-Omics Approaches to Discover Biomarkers of Thyroid Eye Disease: A Systematic Review. | Int J Biol Sci | 2024 | https://conductscience.org/library/papers/39664569 | PubMed |
| 39559327 | miR-101-3p suppresses proliferation of orbital fibroblasts by targeting pentraxin-3 in thyroid eye disease. | PeerJ | 2024 | https://conductscience.org/library/papers/39559327 | PubMed |
| 38536014 | Novel insights into the pathogenesis of thyroid eye disease through ferroptosis-related gene signature and immune infiltration analysis. | Aging (Albany NY) | 2024 | https://conductscience.org/library/papers/38536014 | PubMed |
| 38054982 | Molecular Biomarkers in Thyroid Eye Disease: A Literature Review. | Ophthalmic Plast Reconstr Surg | 2023 | https://conductscience.org/library/papers/38054982 | PubMed |
| 37059863 | Machine learning-based prediction of diagnostic markers for Graves' orbitopathy. | Endocrine | 2023 | https://conductscience.org/library/papers/37059863 | PubMed |
| 37025408 | The crossroad between autoimmune disorder, tissue remodeling and cancer of the thyroid: The long pentraxin 3 (PTX3). | Front Endocrinol (Lausanne) | 2023 | https://conductscience.org/library/papers/37025408 | PubMed |
| 35066781 | A systematic review of multimodal clinical biomarkers in the management of thyroid eye disease. | Rev Endocr Metab Disord | 2022 | https://conductscience.org/library/papers/35066781 | PubMed |
| 33613444 | Microarray Data of Lacrimal Gland Implicates Dysregulated Protein Processing in Endoplasmic Reticulum in Graves' Ophthalmopathy. | Front Endocrinol (Lausanne) | 2020 | https://conductscience.org/library/papers/33613444 | PubMed |
| 32457885 | Exploring the Role of SRC in Extraocular Muscle Fibrosis of the Graves' Ophthalmopathy. | Front Bioeng Biotechnol | 2020 | https://conductscience.org/library/papers/32457885 | PubMed |
| 32300954 | Transforming growth factor-β1 suppress pentraxin-3 in human orbital fibroblasts. | Endocrine | 2020 | https://conductscience.org/library/papers/32300954 | PubMed |
| 31538314 | Immunohistochemical analysis of human orbital tissue in Graves' orbitopathy. | J Endocrinol Invest | 2020 | https://conductscience.org/library/papers/31538314 | PubMed |
| 31258675 | RNA-seq analysis of blood of valproic acid-responsive and non-responsive pediatric patients with epilepsy. | Exp Ther Med | 2019 | https://conductscience.org/library/papers/31258675 | PubMed |
Genes9
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| APCS | 325 | PubTator's text mining | https://conductscience.org/library/genes/325 | NCBI Gene |
| CRP | 1401 | PubTator's text mining | https://conductscience.org/library/genes/1401 | NCBI Gene |
| CXCR6 | 10663 | PubTator's text mining | https://conductscience.org/library/genes/10663 | NCBI Gene |
| FCN1 | 2219 | PubTator's text mining | https://conductscience.org/library/genes/2219 | NCBI Gene |
| GAPDH | 2597 | PubTator's text mining | https://conductscience.org/library/genes/2597 | NCBI Gene |
| PTX3 | 5806 | PubTator's text mining | https://conductscience.org/library/genes/5806 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
| TNFAIP6 | 7130 | PubTator's text mining | https://conductscience.org/library/genes/7130 | NCBI Gene |
| TSHR | 7253 | PubTator's text mining | https://conductscience.org/library/genes/7253 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29675428
GET https://conductscience.org/api/papers/v1/29675428/references?page=2